BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19344240)

  • 21. Telbivudine (Tyzeka) for chronic Hepatitis B.
    Med Lett Drugs Ther; 2007 Jan; 49(1253):11-2. PubMed ID: 17261968
    [No Abstract]   [Full Text] [Related]  

  • 22. Telbivudine.
    Keam SJ
    Drugs; 2007; 67(13):1917-29. PubMed ID: 17722961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telbivudine: a review of its use in compensated chronic hepatitis B.
    McKeage K; Keam SJ
    Drugs; 2010 Oct; 70(14):1857-83. PubMed ID: 20836578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients.
    Yang JX; Liu BM; Li XG; Yan CH; Xu J; Sun XW; Wang YH; Jiao XJ; Yan L; Dong JP; Hou CS; Abuduheilili X; Li T; Zhuang H
    Antivir Ther; 2010; 15(8):1171-8. PubMed ID: 21149924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Telbivudine treatment on cirrhosis resulting from chronic hepatitis B].
    Liang J; Han T; Xiao SX
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):24-7. PubMed ID: 19203447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacotherapy of hepatitis B infection: a brief review.
    Quan DJ
    Nephrol Nurs J; 2008; 35(5):507-10, 534. PubMed ID: 18856082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy of chronic hepatitis B: focus on telbivudine.
    Gaeta GB; Stornaiuolo G
    Dig Liver Dis; 2007 Nov; 39 Suppl 3():S372-8. PubMed ID: 18063258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telbivudine: a new nucleoside analogue for the treatment of chronic hepatitis B.
    Han SH
    Expert Opin Investig Drugs; 2005 Apr; 14(4):511-9. PubMed ID: 15882124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of telbivudine treatment for hepatitis B e antigen-positive chronic hepatitis B patients with poor response to adefovir dipivoxil.
    Li Y; Zhang Y; Wang JP; Lian JQ; Bai XF
    J Viral Hepat; 2013 Apr; 20 Suppl 1():46-51. PubMed ID: 23458524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New first line therapy of chronic hepatitis B. Primary therapy goal: effective virus suppression].
    MMW Fortschr Med; 2007 Jul; 149(29-30):60. PubMed ID: 17703694
    [No Abstract]   [Full Text] [Related]  

  • 31. Telbivudine for the treatment of chronic hepatitis B infection.
    Hartwell D; Jones J; Harris P; Cooper K
    Health Technol Assess; 2009 Oct; 13 Suppl 3():23-30. PubMed ID: 19846025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telbivudine: a new treatment for chronic hepatitis B.
    Amarapurkar DN
    World J Gastroenterol; 2007 Dec; 13(46):6150-5. PubMed ID: 18069753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice.
    Tsai MC; Lee CM; Chiu KW; Hung CH; Tung WC; Chen CH; Tseng PL; Chang KC; Wang JH; Lu SN; Yen YH; Hu TH
    J Antimicrob Chemother; 2012 Mar; 67(3):696-9. PubMed ID: 22174039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early viral kinetics of telbivudine and entecavir: results of a 12-week randomized exploratory study with patients with HBeAg-positive chronic hepatitis B.
    Suh DJ; Um SH; Herrmann E; Kim JH; Lee YS; Lee HJ; Lee MS; Lee YJ; Bao W; Lopez P; Lee HC; Avila C; Zeuzem S
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1242-7. PubMed ID: 20028815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telbivudine, a nucleoside analog inhibitor of HBV polymerase, has a different in vitro cross-resistance profile than the nucleotide analog inhibitors adefovir and tenofovir.
    Seifer M; Patty A; Serra I; Li B; Standring DN
    Antiviral Res; 2009 Feb; 81(2):147-55. PubMed ID: 19028525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
    Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX
    J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B.
    Lai CL; Leung N; Teo EK; Tong M; Wong F; Hann HW; Han S; Poynard T; Myers M; Chao G; Lloyd D; Brown NA;
    Gastroenterology; 2005 Aug; 129(2):528-36. PubMed ID: 16083710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telbivudine in the treatment of chronic hepatitis B.
    Hadziyannis SJ; Vassilopoulos D
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):13-22. PubMed ID: 19072366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Telbivudine in the management of HIV/HBV coinfection. Treating hepatitis B without HIV trouble].
    MMW Fortschr Med; 2009 Apr; 151(18):62-3. PubMed ID: 19769080
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.
    Chen Y; Li X; Ye B; Yang X; Wu W; Chen B; Pan X; Cao H; Li L
    Antiviral Res; 2011 Jul; 91(1):23-31. PubMed ID: 21549152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.